Literature DB >> 26597490

Pharmacologic Management of Pediatric Hypertension.

Jason Misurac1, Kristen R Nichols2,3, Amy C Wilson4.   

Abstract

Hypertension in children is common, and the prevalence of primary hypertension is increasing with the obesity epidemic and changing dietary choices. Careful measurement of blood pressure is important to correctly diagnose hypertension, as many factors can lead to inaccurate blood pressure measurement. Hypertension is diagnosed based on comparison of age-, sex-, and height-based norms with the average systolic and diastolic blood pressures on three separate occasions. In the absence of hypertensive target organ damage (TOD), stage I hypertension is managed first by diet and exercise, with the addition of drug therapy if this fails. First-line treatment of stage I hypertension with TOD and stage II hypertension includes both lifestyle changes and medications. First-line agents include angiotensin-converting enzyme (ACE) inhibitors, thiazide diuretics, and calcium-channel blockers. Hypertensive emergency with end-organ effects requires immediate modest blood pressure reduction to alleviate symptoms. This is usually accomplished with IV medications. Long-term reduction in blood pressure to normal levels is accomplished gradually. Specific medication choice for outpatient hypertension management is determined by the underlying cause of hypertension and the comparative adverse effect profiles, along with practical considerations such as cost and frequency of administration. Antihypertensive medication is initiated at a starting dose and can be gradually increased to effect. If ineffective at the recommended maximum dose, an additional medication with a complementary mechanism of action can be added.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26597490     DOI: 10.1007/s40272-015-0151-3

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN: 1174-5878            Impact factor:   3.022


  54 in total

Review 1.  Expert consensus document on beta-adrenergic receptor blockers.

Authors:  José López-Sendón; Karl Swedberg; John McMurray; Juan Tamargo; Aldo P Maggioni; Henry Dargie; Michal Tendera; Finn Waagstein; Jan Kjekshus; Philippe Lechat; Christian Torp-Pedersen
Journal:  Eur Heart J       Date:  2004-08       Impact factor: 29.983

2.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

Review 3.  Ambulatory blood pressure monitoring in children and adolescents: coming of age?

Authors:  Empar Lurbe; María Isabel Torró; Julio Alvarez
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

4.  Role for aldosterone in blood pressure regulation of obese adolescents.

Authors:  A P Rocchini; V L Katch; R Grekin; C Moorehead; J Anderson
Journal:  Am J Cardiol       Date:  1986-03-01       Impact factor: 2.778

5.  Prevalence of and trends in dyslipidemia and blood pressure among US children and adolescents, 1999-2012.

Authors:  Brian K Kit; Elena Kuklina; Margaret D Carroll; Yechiam Ostchega; David S Freedman; Cynthia L Ogden
Journal:  JAMA Pediatr       Date:  2015-03       Impact factor: 16.193

6.  Comparison of auscultatory and oscillometric blood pressures.

Authors:  M K Park; S W Menard; C Yuan
Journal:  Arch Pediatr Adolesc Med       Date:  2001-01

7.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

8.  Prevalence of hypertension and pre-hypertension among adolescents.

Authors:  Karen L McNiece; Timothy S Poffenbarger; Jennifer L Turner; Kathy D Franco; Jonathan M Sorof; Ronald J Portman
Journal:  J Pediatr       Date:  2007-06       Impact factor: 4.406

9.  Blood pressure in children with chronic kidney disease: a report from the Chronic Kidney Disease in Children study.

Authors:  Joseph T Flynn; Mark Mitsnefes; Christopher Pierce; Steven R Cole; Rulan S Parekh; Susan L Furth; Bradley A Warady
Journal:  Hypertension       Date:  2008-08-25       Impact factor: 10.190

10.  Secondary hypertension in overweight and stage 1 hypertensive children: a Midwest Pediatric Nephrology Consortium report.

Authors:  Gaurav Kapur; Maheen Ahmed; Cynthia Pan; Mark Mitsnefes; Myra Chiang; Tej K Mattoo
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-01       Impact factor: 3.738

View more
  2 in total

1.  Antihypertensive drugs use over a 5-year period among children and adolescents in Beijing, China: An observational study.

Authors:  Yao Wu; Yaying Cao; Jing Song; Yaohua Tian; Mengying Wang; Man Li; Xiaowen Wang; Zhe Huang; Lin Li; Yaling Zhao; Xueying Qin; Yonghua Hu
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.889

Review 2.  Drug dosing in children with obesity: a narrative updated review.

Authors:  Francesca Gaeta; Valeria Conti; Angela Pepe; Pietro Vajro; Amelia Filippelli; Claudia Mandato
Journal:  Ital J Pediatr       Date:  2022-09-08       Impact factor: 3.288

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.